FindMyKOL
Clinical trialNCT06134232RecruitingPhase 2Interventional

Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T

SponsorDendreonEnrollment400Metastatic Castration-Resistant Prostate Cancer (mCRPC)
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

A multicenter, open-label, prospective study to investigate immune boost response changes in patients with metastatic castrate-resistant prostate cancer (mCRPC).

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

31 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Arizona Urology Specialists

    Tuscon, Arizona, United States

    Recruiting
  • City of Hope - National Medical Center

    Duarte, California, United States

    Recruiting
  • Urology Associates of Central California Medical Group

    Fresno, California, United States

    Recruiting
  • Unio Health Partners - Genesis Research, Llc

    San Diego, California, United States

    Recruiting
  • Colorado Urology

    Lakewood, Colorado, United States

    Recruiting
  • Advanced Urology Institute

    Daytona Beach, Florida, United States

    Recruiting
  • Advanced Urology Institute

    Largo, Florida, United States

    Recruiting
  • Advanced Urology Institute

    Ocala, Florida, United States

    Recruiting
  • Florida Urology Partners

    Riverview, Florida, United States

    Recruiting
  • Associated Urological Specialists

    Chicago Ridge, Illinois, United States

    Active, not recruiting
  • Uropartners

    Glenview, Illinois, United States

    Recruiting
  • Advanced Urology Associates

    New Lenox, Illinois, United States

    Recruiting
  • Urology of Indiana

    Carmel, Indiana, United States

    Recruiting
  • First Urology

    Jeffersonville, Indiana, United States

    Recruiting
  • Urologic Specialists of Northwest Indiana

    Merrillville, Indiana, United States

    Recruiting
  • Chesapeake Urology Research Associates

    Towson, Maryland, United States

    Recruiting
  • Michigan Institute of Urology

    Troy, Michigan, United States

    Recruiting
  • Specialty Clinical Research of St. Louis

    St Louis, Missouri, United States

    Recruiting
  • Integrated Medical Professionals

    North Hills, New York, United States

    Recruiting
  • Associated Medical Professionals of Ny

    Syracuse, New York, United States

    Recruiting
  • Associated Urologists of North Carolina

    Raleigh, North Carolina, United States

    Recruiting
  • the Urology Group

    Cincinnati, Ohio, United States

    Recruiting
  • Central Ohio Urology Group

    Gahanna, Ohio, United States

    Recruiting
  • Oregon Urology Institute

    Springfield, Oregon, United States

    Recruiting
  • Midlantic Urology

    Bala-Cynwyd, Pennsylvania, United States

    Recruiting
  • Keystone Urology Specialists

    Lancaster, Pennsylvania, United States

    Recruiting
  • Lowcountry Urology Institute

    Charleston, South Carolina, United States

    Recruiting
  • Carolina Urologic Research Center, Llc

    Myrtle Beach, South Carolina, United States

    Recruiting
  • Urology Associates of Nashville

    Nashville, Tennessee, United States

    Recruiting
  • Urology of Virginia

    Virginia Beach, Virginia, United States

    Recruiting
  • Spokane Urology

    Spokane, Washington, United States

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
2 Oct 2023
Primary completion
31 Dec 2031
Completion
30 Jun 2032
Last update posted
27 Aug 2025
Registered enrollment
400
Registry id
NCT06134232

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.